Floatz logo

Interferon Gamma-1B

Osteopetrosis

FDA Office of Orphan Products Developmentprotein_peptidePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Osteopetrosis cohort.

Asset / SponsorPhaseRating
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Cyclophosphamide
Columbia University
Phase 2/3B
Rabbit Anti-Thymocyte Globulin
Columbia University
Phase 2/3B

View all 10 →

Same molecule, other indications

Interferon Gamma-1B is also rated in:

cancer of unknown primary siteDormant
BB
Indicative ·
64 / 100
View asset →
pulmonary fibrosisDormant
BB
Indicative ·
64 / 100
View asset →
lung disorderDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →